Subbu Sundries — Recapping Recent Observations and Setting the Stage for This Week

Research evidence excerpt

Subbu Sundries — Recapping Recent Observations and Setting the Stage for This Week

DIAGNOSTICS & LIFE SCIENCES TOOLS

May 26, 2026

its ECO Synthesis Manufacturing Platform.

• 5/20: RGEN published its 2025 Corporate Sustainability Report. Highlights include 100%

renewable electricity across US and European manufacturing and a 14% Y/Y reduction

in global water withdrawals.

• 5/20: NTRA announced the EXPAND trial for its Fetal Focus single-gene NIPT has

surpassed 2,000 patients enrolled. Enrollment has more than doubled in the last year.

• 5/20: LH launched MyLabcorp, an AI-powered mobile app that combines lab results,

educational content, and an AI assistant to help patients understand results and identify

health trends over time.

• 5/20: QGEN launched QIA Agent, an AI-powered digital assistant that uses a

conversational interface to connect product information, experiment planning, and

ordering tools across QGEN's Sample to Insight workflows.

• 5/21: NTRA announced an expansion of its Austin operations with a new dedicated

sequencing facility (expected to be the largest in the world) and additional lab space.

• 5/21: TEM launched the ArteraAI Prostate Test for clinical use. The test applies AI

to histopathology biopsy images and clinical data to estimate prostate cancer-specific

mortality risk in patients with metastatic hormone-sensitive prostate cancer (mHSPC).

• 5/21: ILMN confirmed the election of David P. King to its Board of Directors.

• 5/21: NTRA highlighted 35 studies at ASCO 2026, including three oral presentations.

• 5/21: A launched the 1290 Infinity III Fluorescence Detector for UHPLC workflows.

• 5/21: SRT3 opened a new competence center in Freiburg, Germany, focused on

developing and producing consumables for the C> market. The €140M+ investment